TEL-AVIV, Israel and PORTLAND, Ore.--(BUSINESS WIRE)--Cheetah Medical today announced the European launch of its new Reliant® 2.0 System. In addition to core hemodynamic parameters including Cardiac Output (CO), Cardiac Index (CI) and Stroke Volume (SV), the Reliant 2.0 adds new parameters to provide a comprehensive suite of information for hemodynamic monitoring - all without the need for invasive modalities with the associated potential costs and risks. The new parameters include Noninvasive Blood Pressure (NIBP)1, Total Peripheral Resistance (TPR),1 Stroke Volume Variation (SVV), Cardiac Power (CP), and Change in Thoracic Fluid Content (TFCd). The Reliant 2.0 System will be showcased at the American Society of Anesthesiology Annual Meeting in Orlando, Florida through October 21st, with live, interactive demonstrations held at the Cheetah Medical exhibit #2646.
